Chiara Cattaneo

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia — Italy

Medicine · Health Sciences

42h-index7.2kcitations337works2.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lymphoma Diagnosis and Treatment(58), Acute Myeloid Leukemia Research(54), Neutropenia and Cancer Infections(47), Chronic Lymphocytic Leukemia Research(44), Viral-associated cancers and disorders(41)

Publications336 total

Disrupting resistance: novel therapeutic approaches to combat multidrug resistance in fusion-negative rhabdomyosarcoma
Cancer Drug Resistance·2025Open Access
Impact of MYC alterations in de novo large B-cell lymphoma: An italian single center experience
Blood·2025
Crenolanib plus salvage chemotherapy improves outcomes in FLT3-mutant and NPM1 co-mutated relapsed/ refractory (R/R) Acute Myeloid Leukemia (AML): Results from a randomized, placebo-controlled, double-blind trial
Blood·2025Open Access
Mynerva-gimema AML1919 ameliorate Trial: EARLY intensification in FLT3-mutated ACUTE myeloid leukemia based on peripheral blast clearance
Blood·2025Open Access
Infectious complications in elderly newly diagnosed acute myeloid leukemia patients treated with hypomethylating agents with or without venetoclax: Comparison with a historical control group treated with intensive chemotherapy
Blood·2025Open Access
Reassessing ASCT in patients aged 65–75 with multiple myeloma in the era of anti-CD38 therapies
Blood·2025Open Access
Health-related quality of life and symptom burden of patients with vexas: Real-world data from a multicenter observational study
Blood·2025Open Access
Thrombocytopenia and Tedizolid: A new ally in hematologic patients? Brief literature review and a clinical case
2025Open Access
<scp>ET</scp> occurring in <scp>NPM1</scp> ‐mutated <scp>AML</scp> during molecular complete remission: A further potential evolution of a complex disease
British Journal of Haematology·2025· 1 citedOpen Access
American College of Rheumatology Guidance Statement for Diagnosis and Management of <scp>VEXAS</scp> Developed by the International <scp>VEXAS</scp> Working Group Expert Panel
Arthritis & Rheumatology·2025· 12 citedOpen Access
POS1108 ERYTHROID STIMULATING AGENTS IN VEXAS SYNDROME: A MULTICENTER RETROSPECTIVE STUDY OF AN ITALIAN VEXAS COHORT
Annals of the Rheumatic Diseases·2025Open Access
90 | SEVEN‐YEAR FOLLOW‐UP OF THE IELSG42 “MARIETTA” PHASE II TRIAL: DURABLE REMISSIONS FOLLOWING MATRix/RICE INDUCTION AND THIOTEPA AUTOGRAFT IN SECONDARY CNS LYMPHOMA
Hematological Oncology·2025Open Access
286 | THE SHORT‐TERM DOSE‐DENSE CARMEN PROGRAM IS ASSOCIATED WITH BETTER TOLERABILITY AND SIMILAR EFFICACY THAN OTHER INTENSIFIED REGIMENS IN HIGH‐GRADE B‐CELL LYMPHOMAS
Hematological Oncology·2025Open Access
580 | CLINICAL AND PATHOLOGICAL CHARACTERISTICS OF HIGH‐GRADE B‐CELL LYMPHOMAS TRANSFORMED FROM INDOLENT LYMPHOMAS IN HIV‐NEGATIVE AND HIV‐POSITIVE PATIENTS
Hematological Oncology·2025Open Access
Erythroid‐stimulating agents in <scp>VEXAS</scp> syndrome: A retrospective study from an Italian multicentre cohort
British Journal of Haematology·2025· 2 citedOpen Access
Matching-adjusted indirect comparison of CPX- 351 in secondary Acute Myeloid Leukemia between the registrative trial and a real-life study
Annals of Hematology·2025Open Access
HEPATIC FIBROSIS INDICES CORRELATE WITH MICROVASCULAR REMODELLING: PRELIMINARY RESULTS FROM A MASLD PATIENTS’ COHORT
Journal of Hypertension·2025
NON-INVASIVE ASSESSMENT OF LIVER FIBROSIS IDENTIFIES METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE PATIENTS WITH INCREASED ARTERIAL STIFFNESS
Journal of Hypertension·2025
Early identification of functional high-risk multiple myeloma patients after transplant: the predictive power of fat fraction and Response Assessment Category score in diffusion-weighted whole-body magnetic resonance imaging
Haematologica·2025· 2 citedOpen Access
Matching-adjusted indirect comparison of CPX-351 in secondary Acute Myeloid Leukemia between the registrative trial and a real-life study
2025Open Access
page 1 of 17Next →

Frequent Co-authors

Livio Pagano(21), Giuseppe Rossi(20), Anna Candoni(19), Alessandro Busca(17), Alessandro Re(13), Francesco Marchesi(12), Rosa Fanci(11), Erika Borlenghi(11), Mario Delia(10), Paolo Corradini(8), Salvatore Casari(8), Gianpaolo Nadali(7), Francesca Farina(7), Morena Caira(7), Francesco Passamonti(6), Pellegrino Musto(6), Nicola Fracchiolla(6), Fabio Ciceri(6), Franco Aversa(6), Enrico Maria Trecarichi(6)